• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

是否有可能在地方性流行医院中根除耐碳青霉烯类(CRAB)?

Is It Possible to Eradicate Carbapenem-Resistant (CRAB) from Endemic Hospitals?

作者信息

Medioli Filippo, Bacca Erica, Faltoni Matteo, Burastero Giulia Jole, Volpi Sara, Menozzi Marianna, Orlando Gabriella, Bedini Andrea, Franceschini Erica, Mussini Cristina, Meschiari Marianna

机构信息

Department of Infectious Diseases, Azienda Ospedaliero-Universitaria of Modena, 41124 Modena, Italy.

Clinic of Infectious Diseases, Department of Infectious Diseases, University of Modena, 41124 Modena, Italy.

出版信息

Antibiotics (Basel). 2022 Jul 28;11(8):1015. doi: 10.3390/antibiotics11081015.

DOI:10.3390/antibiotics11081015
PMID:36009885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9405503/
Abstract

BACKGROUND

Despite the global efforts to antagonize carbapenem-resistant (CRAB) spreading, it remains an emerging threat with a related mortality exceeding 40% among critically ill patients. The purpose of this review is to provide evidence concerning the best infection prevention and control (IPC) strategies to fight CRAB spreading in endemic hospitals.

METHODS

The study was a critical review of the literature aiming to evaluate all available studies reporting IPC measures to control CRAB in ICU and outside ICU in both epidemic and endemic settings in the past 10 years.

RESULTS

Among the 12 included studies, the majority consisted of research reports of outbreaks mostly occurred in ICUs. The reported mortality reached 50%. Wide variability was observed related to the frequency of application of recommended CRAB IPC measures among the studies: environmental disinfection (100%); contact precautions (83%); cohorting staff and patients (75%); genotyping (66%); daily chlorhexidine baths (58%); active rectal screening (50%); closing or stopping admissions to the ward (33%).

CONCLUSIONS

Despite effective control of CRAB spreading during the outbreaks, the IPC measures reported were heterogeneous and highly dependent on the different setting as well as on the structural characteristics of the wards. Reinforced 'search and destroy' strategies both on the environment and on the patient, proved to be the most effective measures for permanently eliminating CRAB spreading.

摘要

背景

尽管全球都在努力对抗耐碳青霉烯类鲍曼不动杆菌(CRAB)的传播,但它仍是一种新出现的威胁,在重症患者中的相关死亡率超过40%。本综述的目的是提供有关最佳感染预防与控制(IPC)策略的证据,以对抗CRAB在地方流行医院的传播。

方法

该研究是对文献的批判性综述,旨在评估过去10年中所有报告在流行和地方流行环境下,在重症监护病房(ICU)内外控制CRAB的IPC措施的现有研究。

结果

在纳入的12项研究中,大多数是关于主要发生在ICU的暴发的研究报告。报告的死亡率达到50%。在各项研究中,推荐的CRAB IPC措施的应用频率存在很大差异:环境消毒(100%);接触预防措施(83%);医护人员和患者分组(75%);基因分型(66%);每日洗必泰浴(58%);直肠主动筛查(50%);关闭或停止病房收治(33%)。

结论

尽管在暴发期间有效地控制了CRAB的传播,但报告的IPC措施存在异质性,并且高度依赖于不同的环境以及病房的结构特征。事实证明,加强针对环境和患者的“搜索并消灭”策略是永久消除CRAB传播的最有效措施。

相似文献

1
Is It Possible to Eradicate Carbapenem-Resistant (CRAB) from Endemic Hospitals?是否有可能在地方性流行医院中根除耐碳青霉烯类(CRAB)?
Antibiotics (Basel). 2022 Jul 28;11(8):1015. doi: 10.3390/antibiotics11081015.
2
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit.五联感染控制措施根除 ICU 中定植的碳青霉烯类耐药鲍曼不动杆菌
Antimicrob Resist Infect Control. 2021 Aug 19;10(1):123. doi: 10.1186/s13756-021-00990-z.
3
Genomic Characterization of Carbapenem-Resistant Acinetobacter baumannii (CRAB) in Mechanically Ventilated COVID-19 Patients and Impact of Infection Control Measures on Reducing CRAB Circulation during the Second Wave of the SARS-CoV-2 Pandemic in Milan, Italy.意大利米兰新冠疫情第二波期间机械通气的新冠肺炎患者中耐碳青霉烯鲍曼不动杆菌(CRAB)的基因组特征及感染控制措施对减少CRAB传播的影响
Microbiol Spectr. 2023 Mar 28;11(2):e0020923. doi: 10.1128/spectrum.00209-23.
4
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.分析 ICU 患者下呼吸道感染的鲍曼不动杆菌分离株的表型和分子特征。
Microb Pathog. 2019 Mar;128:75-81. doi: 10.1016/j.micpath.2018.12.023. Epub 2018 Dec 15.
5
Adaptations of carbapenem resistant (CRAB) in the hospital environment causing sustained outbreak.耐碳青霉烯类肠杆菌科细菌(CRAB)在医院环境中的适应性导致持续暴发。
J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001345. Epub 2021 Mar 19.
6
Management of a Major Carbapenem-Resistant Outbreak in a French Intensive Care Unit While Maintaining Its Capacity Unaltered.在维持法国重症监护病房容量不变的情况下,应对一次重大的耐碳青霉烯类感染爆发
Microorganisms. 2022 Mar 27;10(4):720. doi: 10.3390/microorganisms10040720.
7
Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014.2008-2014 年法属圭亚那耐碳青霉烯类鲍曼不动杆菌的临床流行病学和耐药机制。
Int J Antimicrob Agents. 2016 Jul;48(1):51-55. doi: 10.1016/j.ijantimicag.2016.03.006. Epub 2016 Apr 25.
8
Effect of daily chlorhexidine bathing on acquisition of carbapenem-resistant Acinetobacter baumannii (CRAB) in the medical intensive care unit with CRAB endemicity.在耐碳青霉烯鲍曼不动杆菌(CRAB)流行的医学重症监护病房中,每日使用洗必泰沐浴对获得CRAB的影响。
Am J Infect Control. 2015 Nov;43(11):1171-7. doi: 10.1016/j.ajic.2015.07.001. Epub 2015 Aug 18.
9
Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in intensive care units and successful outbreak control program.医院重症监护病房耐碳青霉烯鲍曼不动杆菌的医院感染暴发及成功的暴发控制方案。
J Korean Med Sci. 2010 Jul;25(7):999-1004. doi: 10.3346/jkms.2010.25.7.999. Epub 2010 Jun 17.
10
Risk factors for transmission of carbapenem-resistant Acinetobacter baumannii in outbreak situations: results of a case-control study.暴发疫情中耐碳青霉烯鲍曼不动杆菌传播的危险因素:病例对照研究结果。
BMC Infect Dis. 2024 Jan 23;24(1):120. doi: 10.1186/s12879-024-09015-7.

引用本文的文献

1
Emergence of NDM-1- and OXA-23-Co-Producing ST1 Isolates from a Burn Unit in Spain.西班牙一家烧伤病房中同时产生NDM-1和OXA-23的ST1菌株的出现。
Microorganisms. 2025 May 16;13(5):1149. doi: 10.3390/microorganisms13051149.
2
The Multifaceted Landscape of Healthcare-Associated Infections Caused by Carbapenem-Resistant .耐碳青霉烯类药物引起的医疗保健相关感染的多方面情况
Microorganisms. 2025 Apr 5;13(4):829. doi: 10.3390/microorganisms13040829.
3
Carbapenem-resistant and Ventilator-associated Pneumonia; Epidemiology, Risk Factors, and Current Therapeutic Approaches.耐碳青霉烯类与呼吸机相关性肺炎:流行病学、危险因素及当前治疗方法
J Res Pharm Pract. 2024 Dec 23;13(2):33-40. doi: 10.4103/jrpp.jrpp_50_24. eCollection 2024 Apr-Jun.
4
Complex Infection-Control Measures with Disinfectant Switch Help the Successful Early Control of Carbapenem-Resistant Outbreak in Intensive Care Unit.采用消毒剂转换的复杂感染控制措施有助于在重症监护病房成功早期控制耐碳青霉烯类感染暴发。
Antibiotics (Basel). 2024 Sep 11;13(9):869. doi: 10.3390/antibiotics13090869.
5
Hospital and municipal wastewater as a source of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in the environment: a review.医院和城市污水作为环境中耐碳青霉烯鲍曼不动杆菌和铜绿假单胞菌的来源:综述
Environ Sci Pollut Res Int. 2024 Aug;31(36):48813-48838. doi: 10.1007/s11356-024-34436-x. Epub 2024 Jul 25.
6
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries.评估三种抗生素联合方案治疗中低收入国家新生儿败血症的革兰氏阴性菌。
Nat Commun. 2024 May 10;15(1):3947. doi: 10.1038/s41467-024-48296-z.
7
Anti-Acinetobacter Baumannii single-chain variable fragments provide therapeutic efficacy in an immunocompromised mouse pneumonia model.抗鲍曼不动杆菌单链可变片段在免疫抑制小鼠肺炎模型中具有治疗效果。
BMC Microbiol. 2024 Feb 10;24(1):55. doi: 10.1186/s12866-023-03080-9.
8
Risk factors for transmission of carbapenem-resistant Acinetobacter baumannii in outbreak situations: results of a case-control study.暴发疫情中耐碳青霉烯鲍曼不动杆菌传播的危险因素:病例对照研究结果。
BMC Infect Dis. 2024 Jan 23;24(1):120. doi: 10.1186/s12879-024-09015-7.
9
Contribution of active surveillance cultures to the control of hospital-acquired carbapenem-resistant in an endemic hospital setting.主动监测培养对控制流行医院环境中耐碳青霉烯肠杆菌科的作用。
Infect Control Hosp Epidemiol. 2024 Feb;45(2):188-195. doi: 10.1017/ice.2023.162. Epub 2023 Sep 20.
10
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review.肝移植成年患者多重耐药菌早期感染的流行病学与预防:一项叙述性综述
Microorganisms. 2023 Jun 17;11(6):1606. doi: 10.3390/microorganisms11061606.

本文引用的文献

1
The Impact of Antimicrobial Stewardship and Infection Control Interventions on Resistance Rates in the ICU of a Tertiary Care Center in Lebanon.抗菌药物管理与感染控制干预措施对黎巴嫩一家三级医疗中心重症监护病房耐药率的影响
Antibiotics (Basel). 2022 Jul 7;11(7):911. doi: 10.3390/antibiotics11070911.
2
Containment of a carbapenem-resistant Acinetobacter baumannii complex outbreak in a COVID-19 intensive care unit.耐碳青霉烯类鲍曼不动杆菌复合群在 COVID-19 重症监护病房的暴发控制。
Am J Infect Control. 2022 May;50(5):477-481. doi: 10.1016/j.ajic.2022.02.022. Epub 2022 Feb 26.
3
The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature.在 2019 冠状病毒病大流行期间预防和控制耐多药生物体和耳念珠菌爆发的挑战:耐碳青霉烯鲍曼不动杆菌爆发报告和文献系统评价。
Antimicrob Resist Infect Control. 2022 Jan 21;11(1):12. doi: 10.1186/s13756-022-01052-8.
4
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections.美国传染病学会关于治疗产 AmpC β-内酰胺酶肠杆菌科、耐碳青霉烯类鲍曼不动杆菌和嗜麦芽窄食单胞菌感染的指南。
Clin Infect Dis. 2022 Jul 6;74(12):2089-2114. doi: 10.1093/cid/ciab1013.
5
The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network.2019 年冠状病毒病(COVID-19)对 2020 年医疗机构相关感染的影响:国家医疗保健安全网络报告数据摘要。
Infect Control Hosp Epidemiol. 2022 Jan;43(1):12-25. doi: 10.1017/ice.2021.362. Epub 2021 Sep 3.
6
Infections in Times of COVID-19 Pandemic.新冠疫情时期的感染情况
Pathogens. 2021 Aug 10;10(8):1006. doi: 10.3390/pathogens10081006.
7
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit.五联感染控制措施根除 ICU 中定植的碳青霉烯类耐药鲍曼不动杆菌
Antimicrob Resist Infect Control. 2021 Aug 19;10(1):123. doi: 10.1186/s13756-021-00990-z.
8
The Impact of Coronavirus Disease 2019 (COVID-19) on Healthcare-Associated Infections.新型冠状病毒肺炎(COVID-19)对医院获得性感染的影响。
Clin Infect Dis. 2022 May 30;74(10):1748-1754. doi: 10.1093/cid/ciab688.
9
Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.COVID-19 患者重症监护病房中耐多药鲍曼不动杆菌感染。
Infection. 2022 Feb;50(1):83-92. doi: 10.1007/s15010-021-01643-4. Epub 2021 Jun 27.
10
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case-control study.医院内耐碳青霉烯鲍曼不动杆菌直肠定植的危险因素:一项匹配病例对照研究。
Antimicrob Resist Infect Control. 2021 Apr 8;10(1):69. doi: 10.1186/s13756-021-00919-6.